Background
cancer, deaths, Cancer
CANCER, CERVICAL CANCER, CANCER
Edited by: Peng Xie, Shandong First Medical University, ChinaReviewed by: Yunhai Yu, The Second Hospital of Shandong University, China; Xiaolin Li, Shandong First Medical University, China; Zhaopeng Zheng, Guizhou Provincial People’s Hospital, ChinaThis article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in ImmunologyCervical cancer is the fourth most cancer and the fourth leading cause of cancer-related deaths in women worldwide. Current treatment for patients with advanced cervical cancer is limited. And in the urgent demand for novel effective therapies both as the first and the second line treatment for these patients, immunotherapy is developing fast and has made some achievements.